Aged clinical trials

Explore recruiting aged clinical trials.

Recruiting aged studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Aged trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IB1001-304: Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, randomized, placebo-controlled, double-blind, crossover study

Italy, Germany, Austria, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.

Hungary, Poland, Spain, Czechia, Germany, Lithuania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effects of N-Acetyl-L-Leucine on Niemann-Pick disease type C (NPC): A Phase III, randomized, placebo-controlled, double-blind, crossover study

Germany, Netherlands, Czechia, Slovakia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.

Germany, Hungary, Czechia, Poland, Spain, Lithuania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

The NODE-202 Study Multi-Center, Multi-National, Open-Label, Efficacy and Safety Study of Etripamil Nasal Spray in Pediatric Patients with Paroxysmal Supraventricular Tachycardia

Netherlands, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with Crohn’s Disease over a Period of 24 Weeks and an Extended Follow-up Period for a Total of up to 52 Weeks

Spain, Netherlands, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aged trials by city

Aged in Toronto Aged in Vancouver Aged in Montreal Aged in Calgary Aged in Edmonton Aged in Ottawa Aged in Winnipeg Aged in Quebec City Aged in Hamilton Aged in Kitchener Aged in London Aged in Halifax Aged in New York Aged in Los Angeles Aged in Chicago Aged in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease